Condition
Malignant Mesothelioma|Pancreatic Cancer|Ovarian Tumor|Triple Negative Breast Cancer|Endometrial Cancer|Other Mesothelin Positive Tumors
Estimated Enrollment: 20
Age Group: 18 Years to 70 Years (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: s2015-080-06
Study First Received: October 19, 2015
Last Updated: October 19, 2015
Estimated Primary Completion Date: November 2017
Primary Outcome Measures:
Occurrence of Study related adverse events|Anti-tumor responses to CART-meso cell infusions
Sponsors and Collaborators:
Chinese PLA General Hospital
Website Link: https://ClinicalTrials.gov/show/NCT02580747
